Skip to main content

Advertisement

Log in

Recent insights on pharmacological potential of lycopene and its nanoformulations: an emerging paradigm towards improvement of human health

  • Published:
Phytochemistry Reviews Aims and scope Submit manuscript

Abstract

Nutritional antioxidants derived from phytochemicals have been shown to have multifaceted health benefits via the pleiotropic molecular mechanisms. Lycopene is one such aliphatic hydrocarbon carotenoid with no beta-ionone and imparts red coloration to watermelon, tomatoes, and papayas. It is a potent antioxidant and free radical scavenger owing to the presence of 13 carbon–carbon double bonds, out of which 11 are conjugated and the remaining 2 are non-conjugated. It has many biological effects on different types of cancers like prostate, breast, skin, and oral cancer by targeting the Keap1-NF-kB, Keap1-Nrf 2 and PI3K/AKT/m-TOR signalling pathway. In addition to cancer, lycopene also has the ability to modify the gut microbiome, and also work against SARS-CoV-2. This review focuses on the sources, isomers, metabolites, therapeutic targets, mechanistic action, nanoformulations, pharmacokinetics, completed and ongoing clinical trials. In addition to above we are adding the potential ability of lycopene in obesity, infertility, metabolic disorder, gut microbiome, and COVID-19 treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and material

None.

Abbreviations

6-HB:

Six-helical bundle

8-OHdG:

8-Hydroxy-2-deoxyguanosine

8-oxoG:

8-Oxoguanine

ATRA:

All-trans retinoic acid

BC:

β-Carotene

BCO1:

Beta-carotene oxygenase 1

BCO2:

Beta-carotene oxygenase 2

BER:

Base excision repair

BHT:

Butylated hydroxytoluene

CM:

Chylomicrons

COVID-19:

Coronavirus disease 2019

CPT-1:

Carnitine palmitoyl transferase-1

DEN:

Diethylnitrosamine

DFT:

Density functional theory

DMBA:

7,12-Dimethylbenz[a]anthracene

DPPH:

2,2-Diphenyl-1-picrylhydrazyl

ECM:

Extracellular matrix

EMT:

Epithelial-mesenchymal transition

FAS:

Fatty acid synthase

FTIR:

Fourier transform infrared spectroscopy

HCC:

Hepatocellular carcinoma

HDPE:

High density polyethylene

HFD:

High-fat diet

HPLC:

High pressure liquid chromatography

HR:

Heptad repeat

IGF1:

Insulin-like growth factor 1

IkB:

Inhibitor of Kappa

IKK:

Inhibitor of nuclear factor-kb kinase

IL12a:

Interleukin 12

IL1β:

Interleukin-1β

IL6:

Interleukin 6

IUPAC:

International Union of Pure and Applied Chemistry

LDL-C:

Low-density lipoprotein cholesterol

LPS:

Lipopolysaccharide

MAE:

Microwave assisted extraction

MCP1:

Monocyte chemoattractant protein-1

NAD:

Nicotinamide adenine dinucleotide

NAFLD:

Non-alcoholic fatty liver disease

NASH:

Non-alcoholic steatohepatitis

NF-kB:

Nuclear factor kappa light-chain-enhancer of activated B cells

NLC:

Nanostructured lipid carriers

NLS:

Nuclear localization sequence

Nrf2:

Nuclear factor erythroid 2-related factor 2

NTH1:

Nth like DNA glycosylase 1

OC:

Oral cancer

OGG1:

8-Oxoguanine DNA glycosylase

OGTT:

Oral glucose tolerance test

PI3K/AKT/mTOR:

The phosphatidylinositol 3-kinase/mammalian target of the rapamycin signalling

PPARα:

Peroxisome proliferator activated receptor-α

PPARγ:

Peroxisome proliferator activated receptor-γ

ROO:

Refined olive oil

ROS:

Reactive oxygen species

RR:

Retention rate

SARS-CoV-2:

Severe acute respiratory syndrome coronavirus 2

SFE:

Supercritical fluid extraction

SIRT1:

Sirtuin 1

TC:

Total cholesterol

TLR4:

Toll-like receptors 4

TMAO:

Trimethylamine N-oxide

TNF:

Tumour necrosis factor

TP:

Tomato powder

TPA:

12-O-tetradecanoylphorbol-13-acetate

UHPLC:

Ultra-high performance liquid chromatography

WH:

Watermelon-extract

XRD:

X-ray diffraction

PDGF:

Platelet-derived growth factor

VEGF:

Vascular endothelial growth factor

SMC:

Smooth muscle cells

NO:

Nitric oxide

HUVEC:

Human umbilical vein endothelial cells

CAM:

Chorioallantoic membrane

AD:

Alzheimer’s disease

PD:

Parkinson’s disease

MPTP:

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

AMPK:

AMP-activated protein kinase

COX-2:

Cyclooxygenase 2

iNOS:

Inducible nitric oxide synthase

CPK:

Creatine phosphokinase

LDH:

Lactate dehydrogenase

HO-1:

Heme oxygenase-1

GST:

Glutathione S-transferase

MSG:

Monosodium glutamate

GSH:

Glutathione

TBARS:

Thiobarbituric acid reactive substance

uPA:

Urokinase plasminogen activator

MMP-2:

Matrix metalloproteinase

eNOS:

Endothelial nitric oxide synthase

PDGFR:

Platelet-derived growth factor receptor

IGFBP:

Insulin-like growth factor binding protein

JNK:

C-Jun N-terminal kinases

References

Download references

Funding

Council of Scientific and Industrial Research (CSIR) and Department of Science and Technology (DST). Funding will be provided by collaborative Scheme.

Author information

Authors and Affiliations

Authors

Contributions

AKT-Concept development, Designed the project and subtitle, Project administration, Revise manuscript, providing the information from different sources. RD-Writing the original draft manuscript, Draw the figure, AKR-Draw the graphical abstract and make figure. SA-Revised the manuscript and provide continuous suggestion. MAA-Provide the collaborative funding for APC charges, SKM-Visualization, Supervision, Provide extensive suggestion and revise the manuscript.

Corresponding authors

Correspondence to Amit Kumar Tripathi or Sunil Kumar Mishra.

Ethics declarations

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Consent for publication

Yes.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tripathi, A.K., Das, R., Ray, A.K. et al. Recent insights on pharmacological potential of lycopene and its nanoformulations: an emerging paradigm towards improvement of human health. Phytochem Rev (2024). https://doi.org/10.1007/s11101-024-09922-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11101-024-09922-2

Keywords

Navigation